cognitive cybersecurity intelligence

News and Analysis

MedCity FemFwd: Shortcomings in Menopause Care with Dr. Bruce Dorr

In the latest episode of the MedCity FemFwd podcast, Dr. Bruce Dorr, an OB-GYN and senior medical advisor for hormone optimization firm Biote, discusses the inadequate treatment for menopause. His claims the issue arises from insufficient medical training for menopause care.

Source: medcitynews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But

Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it

In a randomized pilot trial of 39 adults, researchers found that participants receiving medically tailored meals or Noom regained about 3.6% of their body weight

Y chromosome loss creates hidden cancer vulnerability in men

A study initiated by a University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu revealed that the loss of the Y chromosome in men’s body

The True Cost of Focusing on Cost Instead of Cost-Effectiveness

When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is

News and Analysis

MedCity FemFwd: Shortcomings in Menopause Care with Dr. Bruce Dorr

Subscribe to newsletter

More Posts

Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder

Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it

Y chromosome loss creates hidden cancer vulnerability in men

The True Cost of Focusing on Cost Instead of Cost-Effectiveness

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company